Regina Groves's most recent trade in Atricure Inc was a trade of 5,401 Common Stock done . Disclosure was reported to the exchange on May 19, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Atricure Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2025 | 5,401 | 36,167 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 8,982 | 16,982 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 5,481 | 5,481 | - | - | Stock Option (Right to Buy) | |
| Fulgent Genetics Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 4,000 | 8,000 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 7,788 | 30,766 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 3,186 | 22,978 (0%) | 0% | 0 | Common Stock | |
| Fulgent Genetics Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 6,759 | 6,759 | - | - | Stock Option (Right to Buy) | |
| Fulgent Genetics Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Fulgent Genetics Inc | Regina E. Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 4,000 | 4,000 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Regina Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 3,564 | 19,792 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Regina Groves | Director | Sale of securities on an exchange or to another person at price $ 74.73 per share. | 15 Sep 2021 | 3,156 | 16,194 (0%) | 0% | 74.7 | 235,848 | Common Stock |
| Atricure Inc | Regina Groves | Director | Sale of securities on an exchange or to another person at price $ 71.95 per share. | 26 May 2021 | 4,208 | 19,350 (0%) | 0% | 72.0 | 302,766 | Common Stock |
| Atricure Inc | Regina Groves | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 1,749 | 23,558 (0%) | 0% | 0 | Common Stock | |
| Atricure Inc | Regina Groves | Director | Purchase of securities on an exchange or from another person at price $ 76.68 per share. | 30 Apr 2021 | 34 | 16,228 (0%) | 0% | 76.7 | 2,607 | Common Stock |
| Atricure Inc | Regina Groves | Director | Sale of securities on an exchange or to another person at price $ 41.83 per share. | 14 Sep 2020 | 6,313 | 21,809 (0%) | 0% | 41.8 | 264,073 | Common Stock |